跳至正文
并购财务顾问 · 亚太区
市场 — 马来西亚

中国买方收购马来西亚医疗服务企业:诊所、专科与区域病患

面向中文读者的马来西亚医疗服务并购指南:中国买方评估诊所、专科医疗、牙科、体检和医疗管理企业时的牌照、医生、患者来源和估值要点。

Daniel Bae··1分钟阅读

为什么马来西亚医疗服务交易看重医生留任?

马来西亚诊所、专科医疗、牙科、体检和医疗管理企业可能具备区域患者和多语种团队。中国买方可通过收购建立东南亚医疗服务平台。

但企业价值高度依赖医生和患者留存。

估值重点

买方应关注医生生产力、患者来源、牌照、付款结构、租约、设备、人员成本、合规记录和正常化EBITDA。

如果收入依赖单一医生或短期医疗旅游客源,估值应更谨慎。

尽职调查重点

尽调应覆盖牌照、医生协议、患者数据、医疗事故、设备、保险、租约、税务、员工和外资限制。

Lyndon如何协助

Lyndon可协助中国买方、马来西亚医疗服务企业和顾问准备估值、资料室、风险清单和交易执行。

About the Author

Daniel Bae

Daniel Bae

Co-founder & CEO, Lyndon Advisory

Daniel is an investment banker with 15+ years of experience in M&A, having advised on deals worth over US$30 billion. His career spans Citi, Moelis, Nomura, and ANZ across London, Hong Kong, and Sydney. He holds a combined Commerce/Law degree from the University of New South Wales. Daniel founded Lyndon Advisory to solve the pain points in M&A, enabling bankers to focus on what matters most — delivering trusted advice to clients.

About Lyndon Advisory

Lyndon Advisory is an M&A advisory firm built for Asia Pacific. We help business owners sell their companies and investors make strategic acquisitions with senior-led execution, disciplined process management, and AI-supported buyer intelligence.

Learn about selling your business